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Abstract
Experiments were conducted to redirect mouse Embryonic Stem (ES) cells from a tumorigenic phenotype to a normal
mammary epithelial phenotype in vivo. Mixing LacZ-labeled ES cells with normal mouse mammary epithelial cells at ratios
of 1:5 and 1:50 in phosphate buffered saline and immediately inoculating them into epithelium-divested mammary fat pads
of immune-compromised mice accomplished this. Our results indicate that tumorigenesis occurs only when normal
mammary ductal growth is not achieved in the inoculated fat pads. When normal mammary gland growth occurs, we find
ES cells (LacZ+) progeny interspersed with normal mammary cell progeny in the mammary epithelial structures. We
demonstrate that these progeny, marked by LacZ expression, differentiate into multiple epithelial subtypes including
steroid receptor positive luminal cells and myoepithelial cells indicating that the ES cells are capable of epithelial
multipotency in this context but do not form teratomas. In addition, in secondary transplants, ES cell progeny proliferate,
contribute apparently normal mammary progeny, maintain their multipotency and do not produce teratomas.
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Introduction
In earlier publications, we demonstrated that dispersed mouse
testicular, neural, bone-marrow-derived cells and mouse and
human cancer cells were redirected to normal mammary epithelial
cell fates when inoculated into epithelium-cleared mammary fat
pads with normal mouse mammary epithelial cells (MEC’s) [1–5].
Mouse embryonic stem cells (referred to as ES cells in these
experiments), are derived from the inner cell mass of the blastocyst
before germ layer formation occurs in the early embryo and are
capable of forming all cell types of the developing and adult mouse
[6]. Because of this unique potential, they can be used to identify
developmentally relevant signals that pattern the embryo to form
tissues and organs. Based on our understanding of somatic cell
reprogramming [1–3] we sought to further investigate the
potential dominant capacity of the mammary stem cell niche.
The following experiments were designed to extend this observa-
tion by defining the inductive signals controlling this process by
starting with the most undifferentiated stem cell, ES cells.
Using mouse ES cells in vivo is often troublesome due to their
tumorigenic potential to form teratomas when injected into
immune compromised hosts [7,8]. Studies by G Barry Pierce
showed that only the undifferentiated cells in these tumors give rise
to teratomas, the differentiated cells do not [6,7,9]. Utilizing these
undifferentiated cells allows evaluation of the mammary microen-
vironment’s ability to reprogram embryonic cells that have not yet
committed to a cell fate, and test the mammary gland’s capacity to
alter the teratoma-forming capability of mouse ES cells. Soriano
[10,11] developed mice designated ROSA Beta-geo 26 where
expression of the Beta-geo reporter is constitutive during
embryonic development. The embryonic stem cell cultures were
derived from these mice. In these cultures LacZ expression marks
all ES cells and makes them easily traceable in our experiments.
Because LacZ expression is constitutive in these ES cells, our host
animals do not need to be made pregnant prior to analysis as in
previous experiments where WAP-Cre expression was the
initiating activity [12]. The ES cells are grown on irradiated
embryonic fibroblasts in the presence of leukemia inhibitory factor
(LIF) to prevent differentiation. Here we demonstrate that the
mammary microenvironment is sufficient to suppress ES cell
induced tumorigenesis and to provide signals necessary to induce
differentiation of ES cells to a mammary cell fate.
Results
MECs direct ES cells to adapt a mammary cell fate
When ES cells are transplanted into the cleared fat pad of nude
mice, teratomas formed in all cases (Table 1, Fig. 1). As few as
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1,000 (1 K) ES cells formed tumors in 4 out 4 transplants into
cleared mammary fat pads. Histological analysis of teratomas
shows evidence of the presence of all three germinal layers
(Fig. 1A). The tumors constitutively expressed Beta-gal, confirmed
by both X-gal staining (Fig. 1B) and immunofluorescence with an
anti- Beta-gal antibody (Fig. 1C) and contained regions that
expressed cytokeratins (Fig. 1D). Based on this data, and using
information we obtained with other cancer reprogramming studies
[4,5], our mixing experiments were performed with 1 K and 10 K
ES cells.
ES cells (1 K and 10 K) were mixed with 50 K mammary
epithelial cells and inoculated into epithelial divested mammary
fat-pads. Resulting morphologically normal mammary outgrowths
contained cells derived from both populations as determined by
the presence of both Beta-gal expressing (blue) and null cells
(Table 1, Fig. 2). X-gal staining (Fig. 2 A–D), and immunofluo-
rescent staining with an anti- Beta-gal antibody (Fig. 2 E–F)
demonstrates that the ES cells are present and contribute to
mammary structures. The ES derived cells were capable of self-
renewal, evidenced by their ability to give rise to progeny present
throughout the mammary epithelial tree of second-generation
tissue transplants (Table 1, Fig. 3).
Partial differentiation of ES cells does not significantly
effect mammary reprogramming
To test whether differentiation of ES cells would enhance the
formation of normal mammary chimeras between the pluripotent
ES cells and mammary epithelial cells and blunt the appearance of
tumors, ES cells were grown in the absence of LIF. ES cells that
have been predisposed to differentiate into neuroectoderm and/or
ectoderm due to LIF removal [13] may be more prone to
differentiate into mammary epithelial stem or progenitor cells and
less tumorigenic when placed into cleared mammary fat pads with
mammary epithelial cells. To determine if partial differentiation of
ES towards a neuroectodermal lineage would improve repro-
gramming efficiency, we removed LIF from the culture media of
the ES cells for 7 days. Transcriptome analysis of ES cells that had
been grown in the absence of LIF demonstrated up-regulation of
genes or signaling pathways known to be required for embryonic
mammary placode development, such as the WNT (Wnt4,
Wnt10b), FGF (Fgf9, FgfR1, FgfR2), Hedgehog (Gli3), Nrg3,
keratins (Table 2). In addition, genes such as Otx2 and Pax6,
believed to be involved in neuroectoderm and/or ectoderm
differentiation [14] [15,16] were also up regulated. Conversely, ES
cells grown in the absence of LIF down-regulated expression of
genes associated with pluripotency and differentiation inhibition
such as Nanog, Cripto/Tdgf1, Sox2, Lefty1/2, and Nodal
(Table 2) [17–19]. Together, these results suggested that the
removal of LIF had successfully driven partial differentiation of the
ES cells away from a totipotent state and towards an ectoderm/
neuroectoderm lineage.
However, as shown in Table 3, removal of LIF did not have an
effect on the tumorigenic potential of ES cells implanted into
cleared mammary fat pads. Teratomas arose from both LIF
treated and untreated ES cells, and the resulting teratomas
exhibited similar transcriptomes (Table S1). Furthermore, LIF
removal failed to elicit a statistically significant difference
(p = 0.1780 according to Fisher’s 262 Exact Test) in ES cell
response to the mammary microenvironment (as measured by
presence of ES derived cells in morphologically normal mammary
outgrowths). Therefore, the mammary microenvironment (fatty
stroma and epithelium) is sufficient to induce ES cell differenti-
ation. Prior in vitro differentiation of ES cells towards a
neuroectoderm/ectodermal cell fate had little to no effect on their
interaction with MEC to form chimeric mammary outgrowths or
on teratoma formation.
Identification of ES cell progeny in chimeric outgrowths
To determine if ES progeny in chimeric outgrowths had
undergone complete differentiation to a mammary epithelial cell
fate, sections from the outgrowths were subjected to immunohis-
tochemical staining for estrogen receptor alpha (ER-alpha),
progesterone receptor (PR) and smooth muscle actin (SMA)
(Fig. 4 A–L). Cells were located which were doubly positive for X-
gal and PR (Fig. 4A–D), for X-gal and ER-alpha (Fig. 4E–H), and
for X-gal and SMA (Fig. 4,I–L). These results demonstrate ES cell
progeny differentiated into three mammary epithelial cell subtypes
(ER-alpha/PR-positive and ER-alpha/PR-negative luminal cell
and myoepithelial cells) when interacting with normal mouse
mammary epithelial cells during gland regeneration in a cleared
mammary fat pad.
Discussion
The reforming mammary gland in epithelium-free mammary
fat pads has been shown to redirect adult stem/progenitor cells
from other organs and tissues to mammary epithelial cell fates [1–
3]. In previous studies with tumor cells in our laboratory, both
mouse and human cancer cells were reprogrammed and produced
non-tumorigenic progeny in regenerating mammary glands when
mixed with normal mammary epithelial cells [4,5]. To test
whether this effect was manifest in mixtures of tumorigenic
totipotent ES cells and mouse mammary epithelial cells, we
utilized mouse embryonic stem cells that constitutively express E.
coli beta-galactosidase. This allowed us to readily identify ES cell
progeny by cell fate mapping in either tumors or in chimeric
mammary outgrowths. In cleared inguinal fat pads of nude mice,
Figure 1. Embryonic stem (ES) cells give rise to teratomas that
constitutively express Beta-gal when inoculated into cleared
mammary fat pads. A) Cross section of ES derived tumors stained
with hematoxylin demonstrates the presence of cell types from all three
germ layers. B) ES cells give rise to tumors that stain positive for X-gal
when inoculated into cleared mammary fat pads. C) Immunohisto-
chemical staining with an anti-b-gal antibody (green) confirms
expression of Beta-gal throughout the teratoma. D) Immunohisto-
chemical staining with an anti-pan keratin antibody (green) reveals
regions of the teratoma with epithelial like structures that express
keratins. Scale Bars: A = 400 mM; B (right and left panels) = 5 mm;
C= 100 mm; D= 400 mm.
doi:10.1371/journal.pone.0062019.g001
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transplanted ES cells alone formed teratomas in all cases, with as
few as 1 K cells. When ES cells were mixed with wild type mouse
mammary epithelial cells before inoculation into the mammary fat
pads of host mice, they uniformly either formed teratomas or were
reprogrammed and contributed non-tumorigenic mammary epi-
thelial cell epithelial progeny of various phenotypes to mammary
epithelial outgrowths. This was true when either 10 K or 1 K ES
cells were mixed with 50 K normal MEC. Larger number (50 K)
ES cells contributions invariably produced teratomas in spite of
the presence of 50 K normal MEC. The embryonic mesenchyme
that subsequently becomes the mammary fat pad in the adult
mouse has the capacity to act as an inductive mesenchyme for the
full development of a variety of embryonic epithelial organs in
tissue recombinant experiments [20,21]. This capacity is lost at 17
days post-coitus in utero and subsequently this organ only supports
the complete development of the mammary epithelial gland and
the hair follicle [21]. In our experiments reported here, we
introduced mouse embryonic cells into the adult mammary fat pad
at various cellular quantities from cultures, which had been
maintained in LIF, to ensure the presence of fully pluripotent
embryonic cells, and in the absence of LIF to allow enhanced
differentiation of the embryonic cells in vitro. In all cases the ES
cells produced teratomas when inoculated by themselves, regard-
less of the presence or absence of LIF in culture. When normal
adult MEC were mixed with ES cells, mammary outgrowths were
produced relatively often where ES cells had contributed progeny
during the regeneration of the mammary epithelium. This was
unaffected by the presence or absence of LIF in the medium the
week before implantation. We speculate that interaction of ES cells
with mammary epithelial cells leads to differentiation of the ES
cells towards a mammary epithelial cell fate. Our evidence
suggests that ES cells differentiate into both luminal and basal
(myoepithelial) mammary epithelial cells. Recent publications
indicate that both luminal and basal mammary epithelial cells can
contribute progeny to mammary epithelial outgrowths upon
transplantation [12,22]. Thus interaction of ES cells with either
luminal or basal mammary epithelium may result in their
differentiation along these distinct mammary epithelial cell fates.
Our results indicate that interaction of ES cells with each other in
the context of the mammary fat pad often leads to tumorigenesis.
Table 1. Inoculation of ES cells.
# of ES Cells # of MEC’s




50,000 0 0/5 5/5
10,000 50,000 5/13 3/13
10,000 0 0/4 4/4
1,000 50,000 8/13 1/13
1,000 0 0/4 4/4
2nd generation NA 6/10 0/10
ES cells are transplanted with or without MEC’s. Teratomas were produced when ES cells were inoculated alone in all cases. When ES cells were mixed with MEC’s
normal growth is achieved for both 10 K and 1 K ES cells, and tumor incidence was reduced. These chimeric populations grew in second transplant generations with
contributions by ES cells.
doi:10.1371/journal.pone.0062019.t001
Figure 2. ES cells contribute to normal mammary outgrowths
when inoculated with normal mammary epithelial cells. A and
C) A whole mount (A) and cross section (C) of a representative chimeric
outgrowth with positive X-gal stain (blue) resulting from the inoculation
of a mixture of 1 K ES cells with 50 K mammary epithelial cells (MECs)
into a cleared mammary fat pad (B and D) A whole mount (B) and cross
section (D) of a representative control outgrowth with negative X-gal
staining resulting from the inoculation 50 K MECs into a cleared
mammary fat pad. E) Immunohistochemical staining with an anti-b-gal
antibody confirms presence of Beta-gal expressing ES derived cells in
mammary structures. F) Control mammary gland stained with the same
anti-Beta-gal antibody. Scale Bars: A, B = 2 mm; C, D= 400 mm; E,
F = 100 mm.
doi:10.1371/journal.pone.0062019.g002
Figure 3. ES cells contribute to secondary mammary out-
growths. A) Mammary whole mount image of an X-gal positive stained
outgrowth resulting from transplantation into a cleared mammary fat
pad of a tissue fragment taken from a first generation ES and MEC
chimeric outgrowth. B) Cross-section of a secondary outgrowth
demonstrates presence of Beta-gal+ cells in mammary epithelial
structures. Scale bars: A = 2 mm; B= 200 mm.
doi:10.1371/journal.pone.0062019.g003
Embryonic Cells Redirected to Non-Tumorigenic Fate
PLOS ONE | www.plosone.org 3 April 2013 | Volume 8 | Issue 4 | e62019
Fragments of the original chimeric mammary outgrowths were
implanted to form second-generation transplants. The ES cell
progeny continued to behave as non-tumorigenic mammary
epithelial cells and contributed to all portions of developing
glands. These results were interpreted to mean that the ES cells
were able to stably occupy the reformed niches in the regenerated
mammary gland, and function within these niches to give rise to
fully differentiated progeny during secondary growth, and be self-
renewed and persist in second transplant generations in the
absence of teratoma formation.
When ES cells were allowed to differentiate in culture (in the
absence of LIF), there was no effect on the tumorigenic potential of
ES cells, or the transcriptome of the resulting teratomas. There
was also no statistically significant effect on the ability of the
mammary microenvironment to induce ES cell differentiation to a
mammary epithelial cell fate. It is possible further differentiation of
Table 2. Genes Differentially Regulated in ES cells grown in the absence of LIF.
Fold Change LOG relative to MEFs





























Table 3. ES cells without LIF inoculations.
# of ES cells # of MEC’s




10,000 0 0/2 2/2
10,000 50,000 5/7 2/7
1,000 0 0/2 2/2
1,000 50,000 4/5 1/5
Data from ES cells grown in the absence of LIF. This allows ES cells to begin to differentiate. When this occurs cells contribute to chimeric outgrowths and retain their
teratoma forming capacity.
doi:10.1371/journal.pone.0062019.t003
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ES cells (to the point where they no longer form teratomas) may
affect reprogramming efficiency, but it is clear from these results
that interaction with the regenerating mammary microenviron-
ment is, in most cases, sufficient to direct ES cells to adopt a
mammary epithelial cell fate and not teratomas.
We did not observe an inhibition or suppression of ES cell
tumorigenesis when ES cells were mixed with MEC at a 1:1
(50 K:50 K) ratio. We hypothesize that interaction between ES
cells leads to a rapid production of teratoma, which overgrows any
evidence for mammary outgrowth. As the ratio between ES cells
and MEC is decreased to 1:5 or 1:50 the chances that ES cells
interact with MEC is increased and their interaction with other ES
cells is decreased. We hypothesize that this interaction is important
to tumor suppression.
Materials and Methods
All mice were housed in Association for Assessment and
Accreditation of Laboratory Animal Care–accredited facilities in
accordance with the NIH Guide for the Care and Use of
Laboratory Animals. The National Cancer Institute (NCI) Animal
Care and Use Committee approved all experimental procedures.
Cell and tissue transplantation
Mammary fat pad clearing and transplantation was performed
on female mice between 3 and 4 weeks of age as previously
described [23–26]. Briefly, mice were anesthetized and endoge-
nous epithelium was removed from the #4 and #9 inguinal fat
pads by surgically removing the proximal portion (from the nipple
to the lymph nodes). Mammary tissue fragments, (1–2 mm2), were
directly inserted into a small cavity in the fat pad created with
watchmaker forceps. Dispersed cells were suspended in 10 ml of
DMEM without serum per injection and inoculated into cleared
mammary fat pads with a Hamilton syringe equipped with a fine
30-gauge needle. Tissue and cell transplants were then allowed to
grow for 12 weeks before harvesting of the glands. Differences in
gland formation and tumorigenesis efficiencies were evaluated
using a two-tailed 262 Fisher’s Exact Test.
Mouse Embryonic Fibroblast (MEFs) and Rosa 26 ES cell
Preparation
Mouse embryonic Rosa 26 ES cells, [27] (A gift from P.
Soriano) were maintained in the undifferentiated state by culture
on irradiated mouse embryonic fibroblast (MEF) (Cat. # 5662.
ATCC, Manassas, VA) feeder layers in high-glucose DMEM
supplemented with 15% fetal bovine serum, 0.1 mmol/L 2-
mercaptoethanol, 1 mmol/L sodium pyruvate, 16 nonessential
amino acids, 2 mmol/L glutamine, 100 U/ml penicillin/strepto-
mycin, and 1000 U/ml murine leukemia inhibitor factor (LIF).
Undifferentiated ES cells growing on mitotically inactivated
embryonic fibroblasts (irradiated with total of 60Gy of gamma
irradiation) were detached with ES medium containing 1.5 mg/ml
collagenase IV. The collected ES cells were then incubated with
0.25% trypsin solution and seeded at 26105 cells in 60-mm plates
that had been pre-coated with 0.1% gelatin.
Mammary Epithelial Cell Preparation
Mammary epithelial cells are isolated according to standard
primary cell culture protocol as follows: Glands were minced into
Figure 4. ES cells differentiate into ERa positive, PR positive, and SMA positive cell types. Immunofluorescent staining for PR (A–D), ER-
alpha (E–H), and SMA (I–L) on chimeric outgrowths from inoculations of 1,000 ES cells with 50,000 MECs. ES cell expression of PR (C and D), ER-alpha
(G and H), and SMA (K and L) is demonstrated by overlay of a bright field (BF) image of the X-gal stain (marking ES cells) with an image of the
immune-fluorescent staining of the antigen. Panels D, H, L are enhanced images of the boxed region shown in panels C, G, and H, respectively. Scale
Bars: A–C, E–G, I–K = 100 mm; D, H, L = 20 mm.
doi:10.1371/journal.pone.0062019.g004
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1–2 mm fragments and incubated overnight at 37uC in complete
medium (DMEM, 10% fetal bovine serum, 1.0 mg/ml porcine
insulin, 1.0 ng/ml EGF, 1.0% penicillin/streptomycin) containing
1 mg/ml Type 1A collagenase (Sigma Aldrich, St Louis MO). The
suspension was then triturated through a 10 ml pipette 3 times and
the cells were pelleted by centrifugation for 10 minutes at 3006g.
The pellet was then washed with twice with an equal volume of
complete medium without collagenase and sheared through a 19-
gauge needle one time. The resulting organoids were pelleted as
before and suspended in 15 ml complete media and cultured in T-
75 flask for 3–4 days under normal cell culture conditions (37uC/
5% CO2). Differential trypsinization was performed to remove
fibroblasts prior to collection of epithelial cells.
X-Gal Staining and whole mounts of Mammary Glands
Glands were spread on glass slides, fixed in paraformaldehyde
(4.0%) for 1–2 h, and permeabilized in 0.01% Nonidet P-40,
0.01% sodium deoxycholate and 2 mM MgCl2 in phosphate
buffer saline overnight at 4uC. Glands were then stained with X-
gal (5-bromo-4-chloro-indolyl-b-D-galactopyranoside) staining so-
lution (5 mM potassium ferricyanide crystalline (K3Fe(CN)6);
5 mM potassium ferricyanide trihydrate (K4Fe(CN)6.3H2O)
1 mg/ml X-gal) for 24–30 hours at 37uC in an incubator. Glands
were then washed in PBS and post-fixed with Carnoy’s fixative
overnight at 4uC. For whole mounts, glands were then dehydrated
in stepwise treatment with ethanol starting with 2670% for
30 min., and then 26100% for 60 min. When fully dehydrated,
the whole mounts were cleared in xylenes for 20 minutes, mounted
on glass slides and cover slipped with Permount (Fisher cat. #
SP15-100) for stereo-microscopic analysis at 5–20X.
Immunohistochemistry
X-gal-stained whole mounts (above) were embedded in paraffin,
sectioned at 6.0 mm, and counterstained with nuclear fast red
(Sigma-Aldrich, St Louis, MO, USA). Immunofluorescence was
performed on deparaffinized sections. Sections were blocked with
10% normal goat serum, or 5% BSA+0.1% Gelatin (for chicken
anti-betagalactosidase) in TBS+0.1% Triton X-100. Primary
antibodies used were rabbit anti-ER-alpha MC-20 (1:50; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-PR (1:75;
Dako, Carpinteria, CA, USA), mouse-anti-SMA 1A4 (1:100;
Zymed/Invitrogen, Carlsbad, CA, USA), chicken anti-beta-
galactosidase (1:100, Abcam, Cambridge MA, USA). Secondary
antibodies used were Alexafluor 568 goat anti-rabbit IgG
(Invitrogen), Alexafluor 568 goat anti-mouse IgG (Invitrogen),
and FITC rabbit anti Chicken IgY (Abcam). Antigen retrieval was
performed by boiling sections for 20 min in pH 9.0 Tris-
EDTA+0.05% Tween-20. Sections were mounted with Prolong
Gold Antifade plus Dapi (Invitrogen).
RNA isolation and quality
Total RNA from ES cells was isolated using QIAshredderTM
(Cat. #79656; Qiagen-Germantown MD); RNeasy Mini kit (Cat.
#74106; Qiagen-Germantown MD) and DNase treated using the
RNase-Free DNase Set (Cat. #79254; Qiagen-Germantown MD)
in accordance with the manufacturer’s instructions.
Total RNA RNA from teratomas were isolated using TRIzol
Reagent (Cat. #15596-018; Life Technologies). RNA quality was
assessed by RNA integrity using the Agilent RNA 6000 Pico Chip
on the Agilent 2100 Bioanalyzer (RNA 6000 Nano LabChip,
Agilent Technologies, Santa Clara, CA, USA).
Real time RT-PCR analysis of a customized gene array
The single strand cDNA from 1mg of total RNA was synthesized
using RT2 first strand kit (Cat. #330401- Qiagen-Germantown
MD). Real-Time PCR was performed according to the User
Manual of RT2 Profiler PCR array system (SABioscience/Qiagen
-Germantown MD) using RT2 SYBR Green ROX qPCR
Mastermix (Cat. #330520- Qiagen-Germantown MD). Thermal
cycling and fluorescence detection were performed using an
Mx3005P Detection System (Stratagene). A customized array was
designed containing genes involved in embryonic stem cell state
and mammary placode development. Data were analyzed using
RT2 Profiler PCR Array Data Analysis version 3.5 (Table S1).
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